Background
- Sickle cell disease (SCD) is the most common inherited blood disorder in the United States and is caused by a mutation of β-globin (HBB MT).
- The risk of developing solid malignancies in this population remains controversial.
- We report the prevalence of HBB mutations across a cohort of solid tumors and clinical outcomes between HBB-Wild type (WT) v Mutant (MT) tumors.